Tethis S.p.A.
PrivateLast Round
Early Funding
Jan 14, 2025
Total Funding Raised
$17.35M
Company Overview
Tethis S.p.A. operates in Healthcare & Life Sciences and is based in Milan. Its latest recorded funding round was an Early Funding round in January 2025.
Tethis S.p.A. is a biotechnology company that develops and commercializes a standardized liquid biopsy platform for cancer diagnostics and management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tethis S.p.A. Comparables
Compare Tethis S.p.A. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cell Microsystems | 83% | |
| nRichDX | 80% | |
| BioFluidica | 79% |
For institutional investors. Book with your work email.
Tethis S.p.A. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 14, 2025 | ||||
| Grant | Mar 5, 2018 | ||||
| Grant | Jun 1, 2016 | ||||
| VC Round | Jul 6, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tethis S.p.A. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Indaco Venture Partners SGR | Early Funding |
| ENEA-Tech and Biomedical Foundation | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 383% MoM.
- Jan 14, 2025
$15.4M raised in early funding.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withSep 21, 2026
Tethis S.p.a. and Everex S.r.l. announced a long-term manufacturing and supply partnership in Italy on Sep 22nd '26, with Everex S.r.l. supporting production and future scale-up.
For institutional investors. Book with your work email.
Tethis S.p.A. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tethis S.p.A.'s valuation, stock price, and market status.
Is Tethis S.p.A. a public or private company?
Tethis S.p.A. is a private company.
What is the current stock price of Tethis S.p.A.?
Tethis S.p.A. is a private company, so its shares have no public market price. Caplight tracks Tethis S.p.A.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tethis S.p.A. worth (valuation)?
Valuation information for Tethis S.p.A. is not publicly available.
Can I buy Tethis S.p.A. stock?
Tethis S.p.A. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tethis S.p.A.'s last funding round?
Tethis S.p.A.'s most recent funding round was Early Funding on January 14, 2025.
Who are the main investors in Tethis S.p.A.?
Key investors in Tethis S.p.A. include ENEA-Tech and Biomedical Foundation.
Will Tethis S.p.A. IPO soon?
No public IPO plans have been announced for Tethis S.p.A..
How can I track Tethis S.p.A. secondary market activity?
Caplight tracks bids, offers, and trades in Tethis S.p.A.'s shares on secondary markets.